Cita APA

Rudiger, A., Breitenstein, A., Arrigo, M., Salzberg, S. P., & Bettex, D. (2014). Suitability, Efficacy, and Safety of Vernakalant for New Onset Atrial Fibrillation in Critically Ill Patients. Hindawi Publishing Corporation.

Citación estilo Chicago

Rudiger, Alain, Alexander Breitenstein, Mattia Arrigo, Sacha P. Salzberg, y Dominique Bettex. Suitability, Efficacy, and Safety of Vernakalant for New Onset Atrial Fibrillation in Critically Ill Patients. Hindawi Publishing Corporation, 2014.

Cita MLA

Rudiger, Alain, et al. Suitability, Efficacy, and Safety of Vernakalant for New Onset Atrial Fibrillation in Critically Ill Patients. Hindawi Publishing Corporation, 2014.